When it comes to prenatal genetic screenings, you want the right test, for the right patient, at the right time, every time. Our QHerit® and QNatal® prenatal testing provide the right testing solution for each patient’s unique pregnancy journey. From preconception genetic testing to postnatal lab testing, we are there every step of the way. Learn more here: https://lnkd.in/eH5tmk7Q
Quest for Health Systems
Hospitals and Health Care
Secaucus, New Jersey 2,849 followers
Powering affordable care by unleashing the full power of diagnostics to help improve patient and hospital health.
About us
Once-in-a-generation challenges are driving hospital leaders to seek transformative healthcare strategies. At Quest, we bring together clinical, operational, and financial leaders to unlock the true potential of diagnostics to improve hospital performance. Everything we do is guided by our commitment to stewardship for your patients, people, and mission. Because it's time for a new kind of collaboration to help hospitals overcome challenges and power better care. We can improve patient and hospital health—together. Get more out of diagnostics. Let us help you find a model that's right for your system at QuestDiagnostics.com/Hospitals.
- Website
-
https://www.questdiagnostics.com/hospitals
External link for Quest for Health Systems
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Secaucus, New Jersey
Updates
-
Tune in to the latest episode of the American College of Healthcare Executives podcast, Beyond Diagnostics: The Executive Case for Lab Collaborations featuring Yuri Fesko MD, our SVP and Chief Medical Officer. In this episode, Dr. Fesko discusses how a strategic ally can assist in building a more resilient and cost-effective health system. Listen here: https://lnkd.in/eSfqN86 *The use of the term does not imply the existence of a legal business entity and employees of the entities are not joint employees. #ACHE #HealthcareInnovation #HealthcareExecutives
🎙️ New podcast episode 🎙️ Quest Diagnostics SVP and Chief Medical Officer, Yuri Fesko MD, will explore how lab partnerships can help healthcare executives tackle pressing financial challenges, alleviate workforce shortages, and strengthen clinical performance. Learn how collaborating with a strategic ally can assist in building a more resilient and cost-effective health system. Listen to the full episode here: https://lnkd.in/eSfqN86 Thank you to Quest Diagonostics – an ACHE Premier Corporate Partner – for making this podcast possible. *The use of the term does not imply the existence of a legal business entity and employees of the entities are not joint employees.
-
-
Healthcare is complex. But when it comes to prenatal genetic screening, let's keep it simple. By teaming up with Quest, you can streamline your diagnostic tests to ensure consistent prenatal care. Plus, we make it easy to integrate lab testing with your EHR system and provide pertinent support for your staff. Discover more here: https://lnkd.in/eH5tmk7Q
-
-
🔍 Discover the impact of genetic screening on patient outcomes. Annually, 30,000 individuals undergo genetic disorder screening, with up to 15% of healthy individuals showing increased risk for treatable diseases. Explore these insights and how your health system can respond to this surge in demand in our white paper. Access the full report here: #GeneticScreening #PatientCare #HealthcareInnovation https://lnkd.in/enzuRrnf
-
-
POLL TIME! Did you know that an estimated 1 in 10 people reported recent use of Novel Psychoactive Substances (NPS)? And did you know that more than half of NPS-positive specimens tested in 2024 contained xylazine, making it the most common NPS?
This content isn’t available here
Access this content and more in the LinkedIn app
-
The need for innovative solutions: Leading the way with NPS testing In the fight against drug misuse, innovative solutions are crucial. Our lab-based NPS testing empowers health systems to detect and monitor emerging synthetic substances, making informed decisions for patient care. Join us in leading the way and combatting drug misuse.
-
-
Ensuring patient safety: Identifying and monitoring emerging synthetic substances Patient safety is paramount, especially in the face of emerging synthetic substances. Our NPS testing capabilities enable health systems to identify and monitor these substances, ensuring comprehensive care for their patients. Partner with us to prioritize patient safety.
-
-
Enhance your drug monitoring panels: Addressing the need for NPS testing As drug misuse continues to evolve, it's crucial to enhance your drug monitoring panels. Our Novel Psychoactive Substances (NPS) testing is a strategic add-on to existing standard panels, enabling the detection of emerging synthetic substances. Stay one step ahead in comprehensive patient care. Contact us to learn more.
-
-
There is still time to join us tomorrow for our webinar, Diagnostic Precision: Your Competitive Edge in Modern Healthcare with the American College of Healthcare Executives where you'll: 🔍 Understand the transformative impact of precision diagnostics 📈 Identify key strategic considerations when developing a comprehensive precision diagnostics framework 🏥Explore methods to measure and maximize diagnostic investment Our distinguished panel of speakers includes our own expert Dr Thomas Slavin and Chief Science Officer/Chief of Medical Oncology, Baptist Health, Miami, Dr Manmeet Ahluwalia. Register for free today: https://lnkd.in/eqJWjCPM #HealthcareInnovation #Webinar #PatientCare
-
-
The evolving challenge of drug misuse: Detecting the undetectable Drug misuse is an evolving challenge that demands innovative solutions. Our Novel Psychoactive Substances (NPS) testing capabilities are designed to detect emerging synthetic substances, providing valuable insights for health systems. Learn how we can help you stay ahead in the fight against drug misuse. https://lnkd.in/etfqK3H2
-